Clinical Trials for CAGE Bio

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CAGE Bio

Clinical Trials (2)

NCT06923228
A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis
PHASE2Not yet recruiting
3 participants
Started: Apr 21, 2025 · Completed: Sep 30, 2025
1 condition1 sponsor0 locations
NCT06810050
Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
PHASE2Recruiting
180 participants
Started: Dec 18, 2024 · Completed: Oct 30, 2025
1 condition1 sponsor16 locations